Find News

Filter articles

Showing 11 to 20 of 2294 results

EFPIA concerned over SPC waiver amendments


Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations.

Washington University wins $31.6m in patent licensing spat


The University of Wisconsin’s licensing arm has been ordered to pay Washington University $31.6 million in a fight over patent licensing relating to one of AbbVie’s kidney drugs.

NHS to save £300m in biosimilar adalimumab deals


The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.

Pfizer secures six-month Lyrica extension in US


The US Food and Drug Administration has granted Pfizer paediatric exclusivity for Lyrica, extending the period of US market exclusivity for the drug by six months.

EUIPO sides with Takeda in trademark appeal


Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

Abbott taken to court over coronary stent patent


California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California.

FDA seeks revamp of medical devices approvals


The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.

New policies weakening IP innovation incentives: report


Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report.

Sun Pharma buys Japanese company for $1m

India, Japan26-11-2018Mergers & acquisitions

India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma.

EU court sides with Merck in Endoceutics trademark appeal


The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22.

Showing 11 to 20 of 2294 results